The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.
The nonprofit organization identified an especially critical gap in accountability for minimal processing and additives — yet to be addressed in the industry. The new Non-UPF Verified label aims to ...
Duo Unveils $10K Garage Improvement Sweeps In Celebration of National DIY Day St. Louis, MO  – April 2, 2025 – On April 1, ...